Literature DB >> 22178687

Structured models of infectious disease: inference with discrete data.

C J E Metcalf1, J Lessler, P Klepac, A Morice, B T Grenfell, O N Bjørnstad.   

Abstract

The usage of structured population models can make substantial contributions to public health, particularly for infections where clinical outcomes vary over age. There are three theoretical challenges in implementing such analyses: (i) developing an appropriate framework that models both demographic and epidemiological transitions; (ii) parameterizing the framework, where parameters may be based on data ranging from the biological course of infection, basic patterns of human demography, specific characteristics of population growth, and details of vaccination regimes implemented; (iii) evaluating public health strategies in the face of changing human demography. We illustrate the general approach by developing a model of rubella in Costa Rica. The demographic profile of this infection is a crucial aspect of its public health impact, and we use a transient perturbation analysis to explore the impact of changing human demography on immunization strategies implemented.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22178687      PMCID: PMC4086157          DOI: 10.1016/j.tpb.2011.12.001

Source DB:  PubMed          Journal:  Theor Popul Biol        ISSN: 0040-5809            Impact factor:   1.570


  27 in total

1.  [Using surveys of schoolchildren to evaluate coverage with and opportunity for vaccination in Costa Rica].

Authors:  Nidia Calvo; Ana Morice; Elizabeth Sáenz; Lissette Navas
Journal:  Rev Panam Salud Publica       Date:  2004-08

2.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

3.  The dynamics of measles in sub-Saharan Africa.

Authors:  Matthew J Ferrari; Rebecca F Grais; Nita Bharti; Andrew J K Conlan; Ottar N Bjørnstad; Lara J Wolfson; Philippe J Guerin; Ali Djibo; Bryan T Grenfell
Journal:  Nature       Date:  2008-02-07       Impact factor: 49.962

4.  Disease in changing populations: growth and disequilibrium.

Authors:  S Tuljapurkar; A M John
Journal:  Theor Popul Biol       Date:  1991-12       Impact factor: 1.570

5.  Seasonality and comparative dynamics of six childhood infections in pre-vaccination Copenhagen.

Authors:  C Jessica E Metcalf; Ottar N Bjørnstad; Bryan T Grenfell; Viggo Andreasen
Journal:  Proc Biol Sci       Date:  2009-09-09       Impact factor: 5.349

6.  Vaccination against rubella and measles: quantitative investigations of different policies.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1983-04

7.  Strategy for rubella vaccination.

Authors:  E G Knox
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

8.  The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome.

Authors:  E Vynnycky; N J Gay; F T Cutts
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

9.  Pathogens, social networks, and the paradox of transmission scaling.

Authors:  Matthew J Ferrari; Sarah E Perkins; Laura W Pomeroy; Ottar N Bjørnstad
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-03-09

10.  Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru.

Authors:  C J E Metcalf; C V Munayco; G Chowell; B T Grenfell; O N Bjørnstad
Journal:  J R Soc Interface       Date:  2010-07-21       Impact factor: 4.118

View more
  19 in total

1.  Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model.

Authors:  F Alarid-Escudero; E A Enns; R F MacLehose; J Parsonnet; J Torres; K M Kuntz
Journal:  Epidemiol Infect       Date:  2018-04-16       Impact factor: 2.451

2.  Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.

Authors:  Amy K Winter; Brian Lambert; Daniel Klein; Petra Klepac; Timos Papadopoulos; Shaun Truelove; Colleen Burgess; Heather Santos; Jennifer K Knapp; Susan E Reef; Lidia K Kayembe; Stephanie Shendale; Katrina Kretsinger; Justin Lessler; Emilia Vynnycky; Kevin McCarthy; Matthew Ferrari; Mark Jit
Journal:  Lancet Glob Health       Date:  2022-10       Impact factor: 38.927

3.  The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies.

Authors:  Nkengafac Villyen Motaze; Zinhle E Mthombothi; Olatunji Adetokunboh; C Marijn Hazelbag; Enrique M Saldarriaga; Lawrence Mbuagbaw; Charles Shey Wiysonge
Journal:  Vaccines (Basel)       Date:  2021-01-25

4.  Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.

Authors:  C J E Metcalf; J Lessler; P Klepac; F Cutts; B T Grenfell
Journal:  Epidemiol Infect       Date:  2012-02-16       Impact factor: 4.434

Review 5.  Modeling infectious disease dynamics in the complex landscape of global health.

Authors:  Hans Heesterbeek; Roy M Anderson; Viggo Andreasen; Shweta Bansal; Daniela De Angelis; Chris Dye; Ken T D Eames; W John Edmunds; Simon D W Frost; Sebastian Funk; T Deirdre Hollingsworth; Thomas House; Valerie Isham; Petra Klepac; Justin Lessler; James O Lloyd-Smith; C Jessica E Metcalf; Denis Mollison; Lorenzo Pellis; Juliet R C Pulliam; Mick G Roberts; Cecile Viboud
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

6.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

7.  Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa.

Authors:  C J E Metcalf; C Cohen; J Lessler; J M McAnerney; G M Ntshoe; A Puren; P Klepac; A Tatem; B T Grenfell; O N Bjørnstad
Journal:  J R Soc Interface       Date:  2013-01-06       Impact factor: 4.118

8.  Balancing evidence and uncertainty when considering rubella vaccine introduction.

Authors:  Justin Lessler; C Jessica E Metcalf
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

9.  Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.

Authors:  Amy Wesolowski; Keitly Mensah; Cara E Brook; Miora Andrianjafimasy; Amy Winter; Caroline O Buckee; Richter Razafindratsimandresy; Andrew J Tatem; Jean-Michel Heraud; C Jessica E Metcalf
Journal:  J R Soc Interface       Date:  2016-04       Impact factor: 4.118

Review 10.  Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.

Authors:  Gwenan M Knight; Nila J Dharan; Gregory J Fox; Natalie Stennis; Alice Zwerling; Renuka Khurana; David W Dowdy
Journal:  Int J Infect Dis       Date:  2015-11-03       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.